elemene has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alafnan, A; Alharby, TN; Anwar, S; Atalay, A; Bender, O; Break, MKB; Celik, I; Dogan, R; Khojali, WMA; Malik, JA; Mollica, A; Rengasamy, KRR | 1 |
1 other study(ies) available for elemene and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Beta Elemene induces cytotoxic effects in FLT3 ITD-mutated acute myeloid leukemia by modulating apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Molecular Docking Simulation; Mutation; Sesquiterpenes | 2023 |